CTXR – citius pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Citius Pharmaceuticals (NASDAQ:CTXR) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $6.00 price target on the stock.
Citius Pharmaceuticals (NASDAQ:CTXR) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules
Citius Pharmaceuticals Announces a Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules
Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences [Yahoo! Finance]
Form 8-K Citius Pharmaceuticals, For: Dec 01
Form SCHEDULE 13G Citius Pharmaceuticals, Filed by: CVI Investments, Inc.
Form 8-K Citius Pharmaceuticals, For: Oct 23
Form 8-K Citius Pharmaceuticals, For: Oct 20
Form 424B5 Citius Pharmaceuticals,
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.